Next Article in Journal
Is Human Chorionic Gonadotropin a Reliable Marker for Testicular Germ Cell Tumor? New Perspectives for a More Accurate Diagnosis
Previous Article in Journal
PD-1-Positive CD8+ T Cells and PD-1-Positive FoxP3+ Cells in Tumor Microenvironment Predict Response to Neoadjuvant Chemoimmunotherapy in Gastric Cancer Patients
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 17
Issue 14
10.3390/cancers17142408
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Cancers 2022, 14(24), 6120.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Afjei et al. A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. Cancers 2022, 14, 6120

by
Rayhaneh Afjei
1,†,
Negar Sadeghipour
1,†,
Sukumar Uday Kumar
1,
Mallesh Pandrala
2,3,
Vineet Kumar
2,
Sanjay V. Malhotra
2,3,4,
Tarik F. Massoud
1,* and
Ramasamy Paulmurugan
1,*
1
Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, 3155 Porter Drive, Palo Alto, CA 94305, USA
2
Department of Radiation Oncology, Stanford University School of Medicine, 3155 Porter Drive, Palo Alto, CA 94305, USA
3
Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97201, USA
4
Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97201, USA
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Cancers 2025, 17(14), 2408; https://doi.org/10.3390/cancers17142408
Submission received: 10 July 2025 / Accepted: 16 July 2025 / Published: 21 July 2025
Browse Figures
Versions Notes

Figure Legend

In the original publication [1], there was a mistake in the legend for Figure S2. The subfigure (D) in Figure S2 refers to Figure S3, not S2 as it was written before. The correct legend appears below:
Figure S2. Whole western blotting membranes to show the location of each band and the intensities. (A) Figure 3C in the main manuscript. (B) Figure 4D in the main manuscript. (C) Figure 4E in the main manuscript. (D) Figure S3 in the Supplemental.

Error in Figure

In the original publication [1], there were mistakes in the arrangement and cropping of representative images from the original figures for Figures S2, S10 and S11.
The correct Figure S2, Figure S10 and Figure S11 with the respective modified legends appear below now. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Afjei, R.; Sadeghipour, N.; Kumar, S.U.; Pandrala, M.; Kumar, V.; Malhotra, S.V.; Massoud, T.F.; Paulmurugan, R. A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. Cancers 2022, 14, 6120. [Google Scholar] [CrossRef] [PubMed]
Cancers 17 02408 g001
Figure S2. Whole western blotting membranes to show the location of each band and the intensities. (A) Figure 3C in the main manuscript. (B) Figure 4D in the main manuscript. (C) Figure 4E in the main manuscript. (D) Figure S3 in the Supplemental.
Figure S2. Whole western blotting membranes to show the location of each band and the intensities. (A) Figure 3C in the main manuscript. (B) Figure 4D in the main manuscript. (C) Figure 4E in the main manuscript. (D) Figure S3 in the Supplemental.
Cancers 17 02408 g001
Cancers 17 02408 g002
Figure S10. Whole western blotting membranes to show the location of each band and the intensities, for Figure 7 in the manuscript.
Figure S10. Whole western blotting membranes to show the location of each band and the intensities, for Figure 7 in the manuscript.
Cancers 17 02408 g002
Cancers 17 02408 g003aCancers 17 02408 g003b
Figure S11. H&E staining of different organs and tumors. NSG mice bearing U87-MG, LN308-p53175 and U87-MG-p53wt cells. The bars represent 50 μm.
Figure S11. H&E staining of different organs and tumors. NSG mice bearing U87-MG, LN308-p53175 and U87-MG-p53wt cells. The bars represent 50 μm.
Cancers 17 02408 g003aCancers 17 02408 g003b
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Afjei, R.; Sadeghipour, N.; Kumar, S.U.; Pandrala, M.; Kumar, V.; Malhotra, S.V.; Massoud, T.F.; Paulmurugan, R. Correction: Afjei et al. A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. Cancers 2022, 14, 6120. Cancers 2025, 17, 2408. https://doi.org/10.3390/cancers17142408

AMA Style

Afjei R, Sadeghipour N, Kumar SU, Pandrala M, Kumar V, Malhotra SV, Massoud TF, Paulmurugan R. Correction: Afjei et al. A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. Cancers 2022, 14, 6120. Cancers. 2025; 17(14):2408. https://doi.org/10.3390/cancers17142408

Chicago/Turabian Style

Afjei, Rayhaneh, Negar Sadeghipour, Sukumar Uday Kumar, Mallesh Pandrala, Vineet Kumar, Sanjay V. Malhotra, Tarik F. Massoud, and Ramasamy Paulmurugan. 2025. "Correction: Afjei et al. A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. Cancers 2022, 14, 6120" Cancers 17, no. 14: 2408. https://doi.org/10.3390/cancers17142408

APA Style

Afjei, R., Sadeghipour, N., Kumar, S. U., Pandrala, M., Kumar, V., Malhotra, S. V., Massoud, T. F., & Paulmurugan, R. (2025). Correction: Afjei et al. A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. Cancers 2022, 14, 6120. Cancers, 17(14), 2408. https://doi.org/10.3390/cancers17142408

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop